ScienceDaily: Biotechnology News |
- Hitting moving RNA drug targets: New way to search for novel drugs
- Genome editing -- a next step in genetic therapy -- corrects hemophilia in animals
- Scientists expose cancer cells' universal 'dark matter'; Findings reveal chaos in biochemical alterations of cancer cells
| Hitting moving RNA drug targets: New way to search for novel drugs Posted: 26 Jun 2011 11:54 AM PDT By accounting for the floppy, fickle nature of RNA, researchers have developed a new way to search for drugs that target this important molecule.  |
| Genome editing -- a next step in genetic therapy -- corrects hemophilia in animals Posted: 26 Jun 2011 11:53 AM PDT Using an innovative gene therapy technique called genome editing that hones in on the precise location of mutated DNA, scientists have treated the blood clotting disorder hemophilia in mice. This is the first time that genome editing, which precisely targets and repairs a genetic defect, has been done in a living animal and achieved clinically meaningful results.  |
| Posted: 26 Jun 2011 11:53 AM PDT Using the latest gene sequencing tools to examine so-called epigenetic influences on the DNA makeup of colon cancer, a team of researchers says its results suggest cancer treatment might eventually be more tolerable and successful if therapies could focus on helping cancer cells get back to normal in addition to strategies for killing them.  |
| You are subscribed to email updates from ScienceDaily: Biotechnology News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment